Aarey Drugs & Pharmaceuticals informs about quarterly statement on investor complaints

08 Jul 2016 Evaluate

Aarey Drugs & Pharmaceuticals has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Aarey Drugs & Pharma Share Price

54.58 -2.87 (-5.00%)
13-Jan-2025 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1748.40
Dr. Reddys Lab 1338.60
Cipla 1443.95
Lupin 2153.80
Zydus Lifesciences 972.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.